Conestoga Capital Advisors, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 310 filers reported holding REPLIGEN CORP in Q1 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Conestoga Capital Advisors, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$112,443,603
+16.5%
707,148
+3.6%
1.93%
+26.0%
Q2 2023$96,554,230
-16.3%
682,555
-0.4%
1.53%
-20.7%
Q1 2023$115,400,847
-0.0%
685,441
+0.5%
1.93%
-10.5%
Q4 2022$115,438,606
-9.4%
681,818
+0.1%
2.16%
-13.4%
Q3 2022$127,434,000
+2.3%
681,063
-11.2%
2.49%
+10.1%
Q2 2022$124,609,000
-14.3%
767,299
-0.7%
2.27%
+3.4%
Q1 2022$145,341,000
-16.1%
772,719
+18.2%
2.19%
-2.7%
Q4 2021$173,179,000
-31.2%
653,901
-25.0%
2.25%
-35.3%
Q3 2021$251,823,000
+23.3%
871,390
-14.8%
3.48%
+18.1%
Q2 2021$204,266,000
+2.3%
1,023,275
-0.4%
2.95%
-2.0%
Q1 2021$199,731,000
+2.0%
1,027,370
+0.5%
3.01%
-3.6%
Q4 2020$195,830,000
+13.9%
1,021,918
-12.3%
3.12%
-10.0%
Q3 2020$171,975,000
+25.5%
1,165,616
+5.1%
3.47%
+16.2%
Q2 2020$137,070,000
+5.7%
1,108,894
-17.4%
2.98%
-21.3%
Q1 2020$129,638,000
+10.8%
1,342,839
+6.1%
3.79%
+34.6%
Q4 2019$117,043,000
+19.3%
1,265,334
-1.1%
2.82%
+12.2%
Q3 2019$98,085,000
-32.8%
1,278,979
-24.7%
2.51%
-31.2%
Q2 2019$145,971,000
+50.9%
1,698,329
+3.7%
3.65%
+35.5%
Q1 2019$96,739,000
+13.5%
1,637,430
+1.3%
2.69%
-0.8%
Q4 2018$85,230,000
-20.8%
1,616,037
-16.8%
2.72%
-1.2%
Q3 2018$107,660,000
+33.8%
1,941,212
+13.4%
2.75%
+6.0%
Q2 2018$80,492,000
+38.7%
1,711,132
+6.7%
2.59%
+16.7%
Q1 2018$58,034,000
-4.2%
1,604,037
-3.9%
2.22%
-4.5%
Q4 2017$60,572,000
+8.8%
1,669,562
+14.9%
2.33%
-5.6%
Q3 2017$55,688,000
+4.0%
1,453,232
+12.5%
2.46%
-11.6%
Q2 2017$53,532,000
+25.1%
1,291,805
+6.3%
2.79%
+7.7%
Q1 2017$42,797,000
+24.0%
1,215,810
+8.6%
2.59%
+12.6%
Q4 2016$34,514,000
+4.4%
1,119,868
+2.3%
2.30%
+1.5%
Q3 2016$33,052,000
+14.2%
1,094,805
+3.5%
2.26%
+5.9%
Q2 2016$28,936,000
-1.4%
1,057,588
-3.4%
2.14%
+7.8%
Q1 2016$29,352,000
+19.7%
1,094,423
+26.3%
1.98%
+0.1%
Q4 2015$24,518,000
+32.4%
866,673
+30.4%
1.98%
+33.6%
Q3 2015$18,514,000
-34.4%
664,775
-2.8%
1.48%
-24.2%
Q2 2015$28,227,000
-10.6%
683,968
-34.2%
1.96%
-9.4%
Q1 2015$31,581,000
+40.7%
1,040,233
-8.2%
2.16%
+38.5%
Q4 2014$22,443,000
-2.4%
1,133,493
-1.9%
1.56%
-7.1%
Q3 2014$23,004,000
-3.3%
1,155,394
+10.6%
1.68%
+5.2%
Q2 2014$23,800,0001,044,3191.60%
Other shareholders
REPLIGEN CORP shareholders Q1 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders